Core Viewpoint - Comcast's Q1 2025 earnings report revealed a higher-than-expected broadband subscriber loss, impacting stock performance despite some revenue and EBITDA growth [1][2]. Financial Performance - Revenue for Q1 2025 was $29.9 billion, a decrease of 0.6% year-over-year, but approximately $100 million above consensus estimates [3]. - Adjusted EBITDA rose to $9.5 billion, reflecting a 1.9% year-over-year increase and about $400 million above estimates [3]. - Adjusted EPS increased by 4.8% year-over-year to $1.09, exceeding estimates by $0.10 [3]. Subscriber Trends - Broadband subscribers decreased by 199,000 quarter-over-quarter to 31.643 million, worse than the consensus estimate of a 146,000 loss [3]. - Video subscribers fell by 427,000 to 12.1 million, exceeding the consensus loss by 11,000 [4]. - Wireless subscribers increased by 323,000, bringing the total to 8.15 million, which was 27,000 above estimates [4]. Strategic Initiatives - Comcast introduced a new 5-year fixed-cost pricing plan starting at $55/month, which includes unlimited data, Wi-Fi, and a free mobile service line for one year [3][4]. - The company anticipates that the new pricing plan will require investment, potentially impacting EBITDA growth [4]. Market and Competitive Landscape - The advertising market remained flat, excluding political and sports influences, with no immediate macroeconomic impacts observed [2]. - Competitive intensity has increased, contributing to subscriber losses and necessitating a strategic transition in pricing [2]. Future Developments - Comcast is planning new attractions, including a Universal Theme Park and Resort in Bedford, England, set to open in 2031, with construction starting in 2026 [6]. - The company reported strong demand for the upcoming Epic Universe, with pre-opening costs of $100 million as previously guided [5].

Financial Data and Key Metrics Changes - Total revenue for Q4 2024 was $164.1 million, an increase of $11.3 million or 7.4% from the prior year [29] - Full year 2024 revenue reached $624 million, exceeding the top end of the original guidance [11] - Adjusted EBITDA for Q4 2024 was $31.4 million, representing a 22.2% increase compared to the prior year [31] - Diluted net income per common share for Q4 2024 was $0.63, slightly down from $0.64 in the prior year [31] - Cash flow from operations for the year was $48.9 million, up from $45.5 million in the prior year [35] Business Line Data and Key Metrics Changes - APUS revenue in Q4 2024 increased to $82.4 million, a 3.8% rise compared to the prior year [31] - Rasmussen's Q4 2024 revenue was $57.5 million, a 9.3% increase year-over-year, with online enrollment up 9% [32] - Hondros College of Nursing saw a 20% revenue increase in Q4 2024, with total enrollment rising 19.3% [34] - Adjusted EBITDA for Rasmussen in Q4 2024 was $5.5 million, compared to $0.6 million in the prior year [33] Market Data and Key Metrics Changes - Overall net course registrations at APUS increased by 7% year-over-year in Q4 2024 [22] - For the full year 2024, APUS total net course registrations increased by 3% compared to 2023 [23] - Rasmussen experienced a 4% year-over-year enrollment increase in Q4 2024, continuing into Q1 2025 with a 7% increase [16] Company Strategy and Development Direction - APEI plans to consolidate its three degree-granting institutions into a single entity, American Public University System, targeting completion by Q4 2025 [24] - The company aims to simplify operations and find revenue and cost synergies through this consolidation [12] - APEI is focusing on enhancing student outcomes and NCLEX pass rates to improve ROI for students [18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth trajectory, with 2025 expected to be a year of revenue and adjusted EBITDA growth [14] - The company anticipates 2025 revenue guidance of $650 million to $660 million and adjusted EBITDA of $75 million to $85 million [14][40] - Management acknowledged challenges in the first quarter due to portal maintenance affecting enrollments but expects recovery as systems are restored [46] Other Important Information - APEI's capital expenditures for 2024 were $21.1 million, with free cash flow for the year at $51.2 million [35] - The company remains net cash positive with total cash and equivalents at $158.9 million as of December 31, 2024 [36] Q&A Session Summary Question: Impact of portal timing on enrollments in Q1 - Management indicated that the portal outage impacted first quarter guidance, with an expected mid-single digits percentage effect [45][46] Question: Timeline for Rasmussen to achieve double-digit adjusted EBITDA margins - Management did not provide specific multi-year guidance but expressed confidence in significant revenue flow-through to the bottom line [50] Question: Drivers of EBITDA contraction year-over-year - Increased advertising and higher labor costs were cited as primary drivers for the expected EBITDA contraction in Q1 2025 [52][53] Question: G&A savings from portfolio consolidation - Management anticipates both revenue and cost synergies from the consolidation, with a focus on long-term growth rather than immediate cost reductions [57][60] Question: Drivers of online growth for Rasmussen - The shift to organic lead generation and hyperlocal marketing strategies were highlighted as key factors driving enrollment growth [62][66]

Financial Data and Key Metrics Changes - The company reported a net income attributable to Universal Health Services per diluted share of $4.96 for Q4 2024, with an adjusted net income of $4.92 per diluted share [6] - Adjusted admissions to acute care hospitals increased by 2.2% year-over-year, while same facility net revenues in the acute care segment rose by 8.7%, driven by a 5.3% increase in net revenue per adjusted admission [6] - Cash generated from operating activities was $658 million in Q4 2024, compared to $452 million in Q4 2023, and $2.067 billion for the full year 2024, up from $1.268 billion in 2023 [9] Business Line Data and Key Metrics Changes - Same facility revenues at behavioral health hospitals increased by 11.1%, primarily due to an 8.7% increase in revenue per adjusted patient day [8] - The company recorded $50 million in net incremental reimbursements from various state supplemental Medicaid programs during Q4 2024, exceeding prior projections [9] - Operating expenses were well managed, with premium pay declining to $60 million in Q4 2024, consistent with the previous two quarters [7] Market Data and Key Metrics Changes - The company anticipates a slight decrease in total consolidated Medicaid supplemental payments for 2025 compared to 2024 [13] - The demand for behavioral services remains solid, with a forecasted growth in same facility adjusted patient days of 2.5% to 3% for 2025 [14] Company Strategy and Development Direction - The company is focused on expanding its outpatient presence and broadening its continuum of care, with plans to open new facilities and enhance technology investments in behavioral hospitals [10][14] - The company aims to maintain a leverage level in the high twos, approaching three, while using free cash flow primarily for share repurchases [61][62] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about a more stable operating environment in 2025, with expectations of mid-single-digit EBITDA growth [13][20] - The current political environment presents uncertainty regarding Medicaid reimbursement, but management believes there is significant political support for Medicaid programs at the state level [15][49] Other Important Information - The company spent $944 million on capital expenditures in 2024, consistent with forecasts, and has plans for new hospital openings in 2025 [10][11] - As of December 31, 2024, the company had $1.17 billion of available borrowing capacity under its revolving credit facility [12] Q&A Session Summary Question: What is driving the higher underlying growth in 2025 despite state supplemental payments forecasted to be down year over year? - Management indicated that core EBITDA growth is driven by solid volume growth, robust pricing, and effective expense control, with a more stable operating environment expected [20] Question: Why is the guidance range for 2025 wider than usual? - Management acknowledged that items beyond their control, such as government reimbursement changes, contribute to the wider range in guidance [24] Question: What is the main reason for the decline in DPP payments? - The decline is primarily due to recognizing DPP payments related to prior periods in 2024, rather than significant changes in specific programs [29] Question: How adequate are the malpractice reserves? - Management stated that they have moved towards the higher end of the range for reserves, hoping to avoid further adjustments in 2025 [32] Question: What are the assumptions for acute revenue growth in 2025? - Management expects mid-single-digit revenue growth in the acute division, split evenly between price and volume [73] Question: How does the company view the impact of the flu season on Q1? - Management noted that while the flu season has been strong, it typically does not have a significant impact on earnings [131] Question: What is the expected impact of new hospital openings on consolidated revenue and EBITDA? - New hospitals are expected to be EBITDA positive, but may cause some cannibalization of existing business, affecting same-store metrics [120]

Caesars Entertainment, Inc. (NASDAQ:CZR) Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ET Company Participants Brian Agnew - SVP, Corporate Finance, Treasury and IR Anthony Carano - President and COO Eric Hession - President, Caesars Sports and Online Gaming Bret Yunker - CFO Thomas Reeg - CEO Conference Call Participants Carlo Santarelli - Deutsche Bank David Katz - Jefferies Brandt Montour - Barclays Daniel Politzer - Wells Fargo Steven Wieczynski - Stifel Barry Jonas - Truist John DeCree - C ...